IP Library Granted Patent US 7,476,242
Granted Patent B2
US 7,476,242 · App. 10/768,778 · Granted Jan 13, 2009

Electrically heated/phase change probe temperature control

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,476,242
App. No.
10/768,778
Granted
Jan 13, 2009
Kind
B2
Abstract

The present invention provides devices and methods for treating tissue. In one embodiment the present invention provides a method of controlling a temperature of an applicator body, the method comprising providing an applicator body that comprises at least one contact surface A coolant is delivered through at least a portion of the applicator body at a substantially constant rate. Energy is delivered to the coolant through a heating element so that the contact surface of the applicator body is cooled to a desired temperature.

Claims (78)

1. A method of controlling a temperature of an applicator body for treating incontinence, the method comprising:

providing an applicator body that comprises at least one electrode surface; delivering a coolant through a conduit in at least a portion of the applicator body at a substantially constant rate;

delivering sufficient heat energy, from within the applicator body, to the at least one electrode surface by energizing one or more heating elements so that the at least one electrode surface of the applicator body is cooled by the coolant to a desired temperature;

delivering therapeutic electrical energy through the at least one cooled electrode surface; and

contacting the at least one electrode surface against a surface adjacent pelvic support tissue.

2. The method of claim 1 wherein the cooled at least one electrode surface cools the contacted tissue that is adjacent the pelvic support tissue to a temperature between 0° C. and 40° C.

3. A method of controlling a temperature of an applicator body for treating incontinence, the method comprising:

providing an applicator body that comprises at least one electrode surface; delivering a coolant through a conduit in at least a portion of the applicator body at a substantially constant rate;

delivering sufficient heat energy, from within the applicator body, to the at least one electrode surface by energizing one or more heating elements so that the at least one electrode surface of the applicator body is cooled by the coolant to a desired temperature; and

delivering therapeutic electrical energy through the at least one cooled electrode surface, wherein the desired temperature is between about −5° C. and about 3° C.

4. The method of claim 3 wherein the desired temperature is about −2° C.

5. A method of controlling a temperature of an applicator body for treating incontinence, the method comprising:

providing an applicator body that comprises at least one electrode surface; delivering a coolant through a conduit in at least a portion of the applicator body at a substantially constant rate;

delivering sufficient heat energy, from within the applicator body, to the at least one electrode surface by energizing one or more heating elements so that the at least one electrode surface of the applicator body is cooled by the coolant to a desired temperature;

delivering therapeutic electrical energy through the at least one cooled electrode surface, wherein the coolant comprises a R134a refrigerant gas; and

contacting the at least one electrode surface against a surface adjacent pelvic support tissue.

6. The method of claim 1 , 3 or 5 further comprising reducing a power level of the energy delivered to the heating element when the therapeutic heating energy is delivered to the at least one electrode surface.

7. A method of controlling a temperature of an applicator body for treating incontinence, the method comprising:

providing an applicator body that comprises at least one electrode surface; delivering a coolant through a conduit in at least a portion of the applicator body at a substantially constant rate;

delivering sufficient heat energy, from within the applicator body, to the at least one electrode surface by energizing one or more heating elements so that the at least one electrode surface of the applicator body is cooled by the coolant to a desired temperature;

delivering therapeutic electrical energy through the at least one cooled electrode surface;

monitoring a temperature of the at least one electrode surface;

adjusting a power level of the energy delivered to the heating element to maintain the at least one electrode surface of the applicator body at substantially the desired temperature; and

contacting the at least one electrode surface against a surface adjacent pelvic support tissue.

8. The method of claim 1 , 3 or 5 wherein the heating element comprises a plurality of resistive heating elements positioned within the applicator body.

9. The method of claim 8 wherein the resistive heating element(s) contact a portion of the applicator body surrounding the coolant.

10. The method of claim 8 wherein the resistive heating element(s) are positioned in such as way as to minimize a flow related spatial distribution of temperature across the contact surface.

11. The method of claim 10 wherein the spatial distribution of temperature across the contact surface is reduced to less than about 2 degrees Celsius.

12. The method of claim 10 wherein the resistive heating element(s) are chosen to be at different wattage values in such a way as to reduce a flow related spatial distribution of temperature across the electrode surface while still permitting use of a single power source.

13. A method of controlling a temperature of an applicator body, the method comprising:

providing an applicator body that comprises at least one electrode surface; delivering a coolant through a conduit in at least a portion of the applicator body at a substantially constant rate;

delivering sufficient heat energy, from within the applicator body, to the at least one electrode surface by energizing one or more heating elements so that the at least one electrode surface of the applicator body is cooled by the coolant to a desired temperature; and

delivering therapeutic electrical energy through the at least one cooled electrode surface, wherein providing the applicator body comprises providing the coolant in a serpentine path for distributing the coolant substantially evenly over the contact surface.

14. An applicator that delivers energy comprising:

an applicator body comprising a proximal portion and a distal portion;

an electrode surface on the distal portion of the applicator body for delivering therapeutic electrical energy therethrough;

a conduit having a coolant that is delivered on a path through at least a part of the distal portion of the applicator body; and

one or more resistive heating elements thermally coupled, from within the applicator body, to the distal portion of the applicator body and entirely beneath the electrode surface to deliver a heating energy to the coolant in the conduit, wherein the energy is sufficient to heat the coolant so that the electrode surface is at a desired temperature, wherein the resistive heating elements are positioned to reduce a temperature differential across the electrode surface to less than about 2 degrees Celsius.

15. The applicator of claim 14 further comprising an RF power source coupled to the electrodes.

16. The applicator of claim 14 further comprising a control assembly that controls the delivery of the coolant and the heating element(s).

17. The applicator of claim 14 wherein the heating energy delivered to the heating element(s) is discontinued when the therapeutic energy is delivered to the electrodes.

18. The applicator of claim 14 further comprising a power supply coupled to the heating element(s), wherein the power supply is controlled with a temperature control algorithm.

19. The applicator of claim 14 wherein the electrode surface defines a proximal end and a distal end, wherein the heating elements are positioned to deliver more energy toward the proximal end of the electrode surface.

20. The applicator of claim 14 wherein a flow of the coolant is substantially constant.

21. The applicator of claim 14 wherein the desired temperature of the electrode-surface is between about −5° C. and about 3° C.

22. The applicator of claim 14 wherein the coolant comprises a R134a refrigerant gas.

23. The applicator of claim 14 further comprising a temperature sensor that monitors a temperature of the electrode surface.

24. An applicator that delivers energy comprising:

an applicator body comprising a proximal portion and a distal portion;

an electrode surface on the distal portion of the applicator body for delivering therapeutic electrical energy therethrough;

a conduit having a coolant that is delivered on a path through at least a part of the distal portion of the applicator body, wherein the coolant path through the distal portion of the applicator is a serpentine path; and

one or more heating elements thermally coupled, from within the applicator body, to the distal portion of the applicator body to deliver a heating energy to the coolant in the conduit, wherein the energy is sufficient to heat the coolant so that the electrode surface is at a desired temperature, and wherein the coolant comprises a R134a refrigerant gas.

25. A system for heating a pelvic support tissue adjacent an intermediate tissue, the system comprising:

a body comprising one or more electrodes oriented for contacting the intermediate tissue adjacent the pelvic support tissue;

a control system coupled to a power source and to the electrode(s), the control system adapted to selectively energize the electrode(s) so as to deliver a therapeutic heating energy through the intermediate tissue to the pelvic support tissue; and

a cooling assembly configured to control a temperature of the electrode(s), wherein the cooling assembly comprises:

a flow conduit positioned in the body to deliver a coolant adjacent the electrode(s);

a heating element positioned entirely under the electrode(s) and flow conduit to deliver energy to the flow conduit from within the body;

a temperature sensor positioned adjacent the electrode that measures a temperature of the electrode, wherein the coolant comprises a R134a gas.

26. The system of claim 25 further comprising the power source, wherein the power source is an RF power source.

27. The system of claim 25 wherein the temperature sensor comprises a thermocouple.

28. A method of controlling a temperature of an applicator body, the method comprising:

providing an applicator body that comprises at least one electrode surface; delivering a coolant through a conduit in at least a portion of the applicator body at a substantially constant rate;

delivering sufficient heat energy, from within the applicator body, to the at least one electrode surface by energizing one or more heating elements so that the at least one electrode surface of the applicator body is cooled by the coolant to a desired temperature, wherein the heating element comprises a plurality of resistive heating elements positioned within the applicator body, and wherein the resistive heating element(s) contact a portion of the applicator body surrounding the coolant; and

delivering therapeutic electrical energy through the at least one cooled electrode surface, wherein the coolant comprises a R134a refrigerant gas.

29. A method of controlling a temperature of an applicator body, the method comprising:

providing an applicator body that comprises at least one electrode surface; delivering a coolant through a conduit in at least a portion of the applicator body at a substantially constant rate;

delivering sufficient heat energy, from within the applicator body, to the at least one electrode surface by energizing one or more heating elements so that the at least one electrode surface of the applicator body is cooled by the coolant to a desired temperature, wherein the heating element comprises a plurality of resistive heating elements positioned within the applicator body in such a way as to minimize a flow related spatial distribution of temperature across the contact surface; and

delivering therapeutic electrical energy through the at least one cooled electrode surface, wherein the coolant comprises a R134a refrigerant gas.

30. A method of controlling a temperature of an applicator body, the method comprising:

providing an applicator body that comprises at least one electrode surface; delivering a coolant through a conduit in at least a portion of the applicator body at a substantially constant rate;

delivering sufficient heat energy, from within the applicator body, to the at least one electrode surface by energizing one or more heating elements so that the at least one electrode surface of the applicator body is cooled by the coolant to a desired temperature, wherein the heating element comprises a plurality of resistive heating elements positioned within the applicator body in such a way as to minimize a flow related spatial distribution of temperature across the contact surface, the spatial distribution of temperature being reduced to less than about 2 degrees Celsius; and

delivering therapeutic electrical energy through the at least one cooled electrode surface, wherein the coolant comprises a R134a refrigerant gas.

31. An applicator that delivers energy comprising:

an applicator body comprising a proximal portion and a distal portion;

an electrode surface on the distal portion of the applicator body for delivering therapeutic electrical energy therethrough;

a conduit that delivers a coolant on a path through at least a part of the distal portion of the applicator body, wherein the coolant path through the distal portion of the applicator is a serpentine path; and

one or more heating elements thermally coupled, from within the applicator body, to the distal portion of the applicator body and entirely beneath the electrode surface to deliver a heating energy to the coolant in the conduit, wherein the energy is sufficient to heat the coolant so that the electrode surface is at a desired temperature.

Assignments (21)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0318. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Sep 6, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 039919/0017 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0260 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0354 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0318 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2011
From: CIT HEALTHCARE LLC
To: SOLARANT MEDICAL, INC.
Reel/Frame 026142/0160 →
SECURITY AGREEMENT Recorded Aug 17, 2006
From: SOLARANT MEDICAL, INC.
To: CIT HEALTHCARE LLC
Reel/Frame 018120/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2006
From: SOLARANT MEDICAL, INC.
To: AMS RESEARCH CORPORATION
Reel/Frame 018001/0598 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2004
From: MATLOCK, GEROGE
To: SOLARANT MEDICAL, INC.
Reel/Frame 015591/0643 →
CHANGE OF NAME Recorded Apr 14, 2004
From: SURX, INC.
To: SOLARANT MEDICAL, INC.
Reel/Frame 014520/0819 →